Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belatacept Conversion in EBV+ Kidney Transplant Recipients
NCT02213068Phase 4Completed
- Start
- Jul 2014
- Primary completion
- Sep 2020
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of belatacept in kidney transplant rejection. Started Jul 2014; status: completed.
02
Drugs
belatacept
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT02213068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02213068.